Jpmorgan Chase & CO Inogen Inc Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Inogen Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 381,479 shares of INGN stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
381,479
Previous 381,479 -0.0%
Holding current value
$2.63 Million
Previous $3.12 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$5.87 - $8.79 $892,592 - $1.34 Million
-152,060 Reduced 28.5%
381,479 $3.12 Million
Q1 2025

May 12, 2025
SELL
$6.8 - $12.53 $635,738 - $1.17 Million
-93,491 Reduced 14.91%
533,539 $3.8 Million
Q4 2024

Feb 12, 2025
SELL
$8.31 - $11.09 $2.24 Million - $2.98 Million
-269,076 Reduced 30.03%
627,030 $5.75 Million
Q3 2024

Dec 26, 2024
BUY
$7.67 - $12.98 $183,243 - $310,105
23,891 Added 2.74%
896,106 $8.69 Million
Q3 2024

Nov 08, 2024
BUY
$7.67 - $12.98 $183,243 - $310,105
23,891 Added 2.74%
896,106 $8.69 Million
Q2 2024

Dec 26, 2024
SELL
$6.3 - $8.95 $150,513 - $213,824
-23,891 Reduced 2.67%
872,215 $7.09 Million
Q2 2024

Aug 12, 2024
SELL
$6.3 - $8.95 $202,299 - $287,393
-32,111 Reduced 3.55%
872,215 $7.09 Million
Q1 2024

Dec 26, 2024
BUY
$5.26 - $10.15 $43,237 - $83,433
8,220 Added 0.92%
904,326 $7.3 Million
Q1 2024

May 10, 2024
BUY
$5.26 - $10.15 $4.46 Million - $8.6 Million
847,043 Added 1478.7%
904,326 $7.3 Million
Q4 2023

Dec 26, 2024
SELL
$4.21 - $6.32 $3.53 Million - $5.3 Million
-838,823 Reduced 93.61%
57,283 $314,000
Q4 2023

Feb 12, 2024
BUY
$4.21 - $6.32 $177,560 - $266,552
42,176 Added 279.18%
57,283 $314,000
Q3 2023

Nov 14, 2023
SELL
$5.14 - $11.28 $269,808 - $592,109
-52,492 Reduced 77.65%
15,107 $78,000
Q2 2023

Aug 11, 2023
BUY
$10.01 - $13.86 $278,638 - $385,806
27,836 Added 70.0%
67,599 $780,000
Q1 2023

May 18, 2023
BUY
$11.88 - $26.0 $342,571 - $749,736
28,836 Added 263.9%
39,763 $496,000
Q1 2023

May 11, 2023
SELL
$11.88 - $26.0 $308,761 - $675,740
-25,990 Reduced 70.4%
10,927 $136,000
Q4 2022

Feb 13, 2023
BUY
$19.14 - $24.55 $45,629 - $58,527
2,384 Added 6.9%
36,917 $728,000
Q3 2022

Nov 14, 2022
BUY
$22.74 - $31.8 $19,215 - $26,871
845 Added 2.51%
34,533 $839,000
Q2 2022

Aug 11, 2022
SELL
$22.88 - $35.28 $30,384 - $46,851
-1,328 Reduced 3.79%
33,688 $815,000
Q1 2022

May 11, 2022
SELL
$28.1 - $35.25 $3.92 Million - $4.91 Million
-139,344 Reduced 79.92%
35,016 $1.14 Million
Q4 2021

Feb 10, 2022
SELL
$29.66 - $44.0 $738,622 - $1.1 Million
-24,903 Reduced 12.5%
174,360 $5.93 Million
Q3 2021

Nov 12, 2021
BUY
$43.09 - $82.26 $8.59 Million - $16.4 Million
199,263 New
199,263 $8.59 Million

Others Institutions Holding INGN

# of Institutions
141
Shares Held
20.2M
Call Options Held
21.7K
Put Options Held
10K
View Full List

About Inogen Inc

INGN Quotes by TradingView
  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $158M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email